Not possible to specify

441 trials 102 recruiting

Filter these 441 trials by phase, country and sponsor.

Open in Search →

A study to test how well different doses of BI 3031185 are tolerated by healthy men and women Recruiting

2024-516921-29-00 Healthy volunteer trial 3 2025-03-25
Eight-Treg study: a phase I dose escalation trial of adoptive immunotherapy with autologous ex vivo expanded regulatory CD8+ T cells in livi… Recruiting

2024-513771-40-01 chronic renal failure requiring kidney transplantation 7 2025-03-03
ASIC Channels and Migraine Disease - Proof-of-Concept Study on the Efficacy of Amiloride in Migraine Aura Prophylaxis Recruiting

2024-516044-25-00 Migraines with aura 10 2025-02-13
A Phase 1/2 Dose-Exploration and Dose-Expansion Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients with Alpha-1 Antitry… Recruiting

2023-509256-34-00 Alpha-1 Antitrypsin Deficiency (AATD)-Associated Lung D 7 2025-02-06
C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant… Recruiting

2024-511652-40-00 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 5 2025-02-05
Measuring the levels of LSD in the human brain using neuroimaging Recruiting

2024-519564-41-00 No medical condition will be examined. 3 2025-01-22
Ketamine for depression and alcohol use disorder Recruiting

2023-506052-24-00 Depression 9 2025-01-20
COLCHICINE IN SECONDARY PREVENTION OF VASCULAR EVENTS AND RENAL PROGRESSION IN PATIENTS WITH MODERATE CHRONIC RENAL DISEASE Recruiting

2023-505868-11-00 CHRONIC RENAL DISEASE 5 2025-01-17
ZELA trial: Phase 2b/3 Multicenter Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developi… Recruiting

2024-513420-41-00 prematurity in neonates 10 2025-01-09
A study in healthy men to test how well different doses of BI 3776528 are tolerated Recruiting

2024-515222-92-00 Healthy volunteer trial 1 2025-01-08
To compare cilastatin vs thiosulfatein renal protection in patients undergoing debulking surgery with intraoperative hyperthermic intraperit… Recruiting

2024-518854-18-00 acute kidney injury 4 2024-12-19
Prospective, multicenter, randomized, open-label, parallel-group controlled phase 3 study of tacrolimus minimization in kidney transplant re… Recruiting

2022-502624-44-00 kidney transplantation 5 2024-12-10
Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study Recruiting

2024-518878-14-01 Inflammatory bowel disease 6 2024-11-25
A Phase 1 Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAS-004, a MEK (1/2) Inhibitor, in … Recruiting

2024-510900-34-00 Solid Tumors 1 2024-11-22
LENVABLA Lenvatinib in neo-adjuvant and adjuvant therapy for poor-prognosis BCLC A HepatoCellular Carcinoma treated by percutaneous ablatio… Recruiting

2024-514606-31-00 Patients with Biopsy-proven or radiologically-suggested 4 2024-10-29
A PHASE 2A, EXPLORATORY, TWO-PART, OPEN-LABLE TRIAL TO EVALUATE DOSE AND SAFETY OF NANOECHO PARTICLE-1 (FERUMOXTRAN) USING NANOECHO IMAGIN… Recruiting

2024-515335-29-00 Rectal cancer 4 2024-10-16
Linezolid or vancomycin surgical site infection prophylaxis LOVip Recruiting

2023-504986-22-00 surgical antibiotic prophylaxis 5 2024-09-30
First-in-human Trial of EGL-001 in Patients with Selected Advanced and/or Metastatic Solid Tumors Recruiting

2024-512921-10-00 Advanced and/or Metastatic Solid Tumors 1 2024-09-27
A study to test how well different doses of BI 3804379 are tolerated by healthy people and patients with MASH Recruiting

2024-513549-36-01 Metabolic Dysfunction-associated Steatohepatitis 1 2024-09-10
HyperChrono Recruiting

2023-506663-33-00 IDIOPATHIC HYPERSOMNIA 4 2024-09-07
Study in children and adolescents for the treatment of recurrent or relapsed solid tumours with the treatment of Lutathera® combined with ol… Recruiting

2024-512613-40-00 Recurrent or relapsed solid tumours expressing somatost 9 2024-08-28
The RED FLASH study Recruiting

2023-507847-13-00 Breast cancer 5 2024-08-09
"Abdominal Aortic Aneurysm Stabilization with mesenchymal stem Cells" Recruiting

2022-501935-18-00 Patients with abdominal aortic aneurysm undergoing endo 4 2024-06-12
Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials – p53abn - RED Randomized phase … Recruiting

2023-503886-44-00 Patients with a histological diagnosis of p53abn HREC, 5 2024-06-10